The Associated Press on MSN10d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
News Medical24d
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
Study reveals how the JAK inhibitor lowers ACE2 expression and viral entry in individuals with a genetic risk variant linked to autoimmune diseases. Study: Tofacitinib Mitigates the Increased SARS ...
Morning Call PA10d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...